2023 Southern Hemisphere Influenza Vaccine

Awarded Limited / Sole Source Justification Posted

Solicitation number
SPE2DP22R0005
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2DP23C0001 Federal contract award
Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical published a Limited/Sole Source Justification Notice to award a one-year firm fixed price contract to an unknown vendor for the 2023 Southern Hemisphere Influenza Vaccine. The justification is to procure 6,000 packages containing a total of 60,000 doses of the Southern Hemisphere Influenza Vaccine from Sanofi Pasteur Inc., as a sources sought notice received only one response and market research found Sanofi Pasteur to be the only approved manufacturer in the US. The contract was awarded on November 3rd, 2022 for an unknown amount to meet the vaccine needs of populations in the Southern Hemisphere from April through September.

Notice text

Redacted J&A

Awarded contract SPE2DP23C0001 to unknown vendor for unknown amount on 2022-11-03.

Files

File Type Posted
Southern Hemisphere vaccine JA_Redacted.pdf PDF

Notice history

Notice Type Posted
This notice Latest Limited / Sole Source Justification
2023 Southern Hemisphere Influenza Vaccine - Solicitation Latest solicitation Solicitation
2023 Southern Hemisphere Influenza Vaccine Pre-Solicitation
2023 Southern Hemisphere Influenza Vaccine Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response Washington, District of Columbia 20024, United States · NAICS 541714 Office of the Assistant Secretary for Preparedness and Response No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity